FdaApplication

ANDA 202083

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHETERO LABS LTD UNIT III
application_typeANDA
approval_date2023-09-14

Products (4)

ProductActive ingredientStrengthDosage form
DARUNAVIRDARUNAVIR150MGTABLET;ORAL
DARUNAVIRDARUNAVIR600MGTABLET;ORAL
DARUNAVIRDARUNAVIR300MGTABLET;ORAL
DARUNAVIRDARUNAVIR400MGTABLET;ORAL

4 products